Processing

Please wait...

Settings

Settings

Goto Application

Offices all Languages Stemming false Single Family Member true Include NPL false
RSS feed can only be generated if you have a WIPO account

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

IC:A61K

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1.WO/2022/104962PREPARATION METHOD FOR AND USE OF PROBIOTIC SYSTEM
WO 27.05.2022
Int.Class C12N 1/20
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
1Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
20Bacteria; Culture media therefor
Appl.No PCT/CN2020/135870 Applicant NANJING UNIVERSITY Inventor DONG, Lei
The present disclosure provides a preparation method for a probiotic system. By means of the method, a stable exogenous probiotic system can be obtained. After administration, the probiotic system can form a stable microenvironment, can achieve the effect of changing the composition of intestinal microbiota, and eventually play a positive role in the treatment of malignant tumors.
2.WO/2022/104692ENGINEERED ANTIBODY, ANTIBODY-DRUG CONJUGATE, AND USE THEREOF
WO 27.05.2022
Int.Class A61K 39/395
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Appl.No PCT/CN2020/130409 Applicant BLISS BIOPHARMACEUTICAL (HANGZHOU) CO., LTD. Inventor XIA, Bing
An isolated IgG antibody includes two identical heavy chains each having a hinge region with an amino acid sequence containing an additional cysteine upstream of the two cysteines in the CPPCP sequence of a native IgG hinge region, and a CH1 domain containing a cysteine at the position of 142 according to the IMGT numbering scheme. ADCs based on the antibody having this architecture are also provided.
3.WO/2022/106057TETRAPEPTIDE AND COMPOSITIONS COMPRISING TETRAPEPTIDES
WO 27.05.2022
Int.Class A61K 8/64
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
8Cosmetics or similar toilet preparations
18characterised by the composition
30containing organic compounds
64Proteins; Peptides; Derivatives or degradation products thereof
Appl.No PCT/EP2021/025445 Applicant THE BOOTS COMPANY PLC Inventor BELL, Michael, David
According to the present invention there is provided a tetrapeptide, capable of inducing dermal extracellular matrix protein upregulation, selected from the group consisting of tetrapeptides having the amino acid sequence U-QTAV-Z wherein Q is used to denote amino acid Glutamine, T is used to denote amino acid Threonine, A is used to denote amino acid Alanine and V is used to denote amino acid Valine, at the N- terminal end, U is independently selected from the group consisting of octanoyl (C8), decanoyl (C10), lauroyl (C12), myristoyl (C14), palmitoyl (C16), stearoyl (C18), biotinoyl, elaidoyl, oleoyle, lipoyle, at the C-terminal end, Z is selected from the group consisting of OH, O R1, NHR1 or NR1 R2, R1 and R2 are independently selected from the group consisting of alkyl, aryl, aralkyl, alkylaryl, alkoxy, saccharide and aryloxy group, which may be linear, branched, cyclical, polycyclic, unsaturated, hydroxylates, carbonylated, phosphorylated and/or sulphurous, said groups comprising from 1 to 24 carbon atoms and being capable of including one or more heteroatoms O, S and/or N.
4.WO/2022/105922SSX2 ANTIGEN DERIVED SHORT PEPTIDES
WO 27.05.2022
Int.Class C07K 7/00
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
7Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Appl.No PCT/CN2021/132192 Applicant XLIFESC, LTD. Inventor LI, Yi
The present invention relates to SSX2 antigen derived short peptides, and in particular to SSX2 derived tumor antigen short peptides, complexes formed by the short peptides and MHC molecules, and uses of the short peptides and complexes. In addition, the present invention also relates to molecules bound to the short peptides or complexes described above, and uses of the molecules.
5.WO/2022/105952PHARMACEUTICAL COMPOSITION
WO 27.05.2022
Int.Class A61K 9/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
Appl.No PCT/CZ2021/050136 Applicant CB21 PHARMA, S.R.O. Inventor STORCH, Jan
The present invention relates to a pharmaceutical composition in the form of suppository, containing cannabidiol, hyaluronic acid or a salt thereof, and a suppository base containing water. The pharmaceutical composition is particularly suitable for use in regenerating and/or healing damaged tissues, or in relieving and/or alleviating pain and inflammation, or in alleviating the symptoms associated with menopause and/or pre-menstrual syndrome.
6.WO/2022/105997FRAGRANCE COMPOSITIONS
WO 27.05.2022
Int.Class A61Q 13/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
QSPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS
13Formulations or additives for perfume preparations
Appl.No PCT/EP2020/082595 Applicant FIRMENICH SA Inventor NORMAND, Valery
The various aspects presented herein relate to the field of perfumery. In particular, the present disclosure provides compositions having an increased and/or improved long- lastingness and/or fragrance profile. In addition, the present disclosure provides methods of using such compositions to increase and/or improve the long-lastingness and/or fragrance profile of a fragrance composition.
7.WO/2022/107032METHOD FOR PREPARING BIODEGRADABLE MICROCAPSULES AND MICROCAPSULES OBTAINED IN THIS MANNER
WO 27.05.2022
Int.Class B01J 13/18
BPERFORMING OPERATIONS; TRANSPORTING
01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
13Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
02Making microcapsules or microballoons
06by phase separation
14Polymerisation, crosslinking
18In situ polymerisation with all reactants being present in the same phase
Appl.No PCT/IB2021/060689 Applicant GEM INNOV Inventor GUILLANEUF, Yohann
Method for manufacturing microcapsules comprising a wall made of polymer material containing an active substance, comprising the following steps: - preparing an oil phase comprising a poly(beta-aminoester) prepolymer, and an active substance constituting the phase to be encapsulated; - preparing an aqueous phase comprising at least one surfactant; - preparing an O/W (oil in water) emulsion by adding the oil phase to the aqueous phase; and - initiating radical polymerisation within the emulsion. A polymerisation initiator must be present in the aqueous and/or oil phase.
8.WO/2022/107182A COMPOSITION OF FENTANYL AND FATTY ACIDS, AND A METHOD OF PREPARATION THEREOF
WO 27.05.2022
Int.Class A61K 9/08
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
08Solutions
Appl.No PCT/JO2020/050011 Applicant UNIVERSITY OF PETRA Inventor ALAKAYLEH, Faisal Tawfiq
The present disclosure provides a pharmaceutical composition comprising Fentanyl and one or more fatty acids with eutectic mixtures capabilities, for use as an analgesic, and a method of preparation thereof.
9.WO/2022/107872OIL-IN-WATER EMULSIFIED COSMETIC
WO 27.05.2022
Int.Class A61K 8/58
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
8Cosmetics or similar toilet preparations
18characterised by the composition
30containing organic compounds
58containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
Appl.No PCT/JP2021/042525 Applicant KAO CORPORATION Inventor MATSUO, Mikano
Provided is an oil-in-water emulsified cosmetic that is excellent in terms of stability over time, UV ray protection, and the suppression of sebum-associated shine. This oil-in-water emulsified cosmetic contains components (A), (B), (C) and (D) and has a content mass ratio of component (B) to component (A), (B)/(A) , of 0.2 to 10. (A) UV-absorbing agent having intramolecular siloxane bonds (B) Highly polymerized silicone oil (C) Poly(meth)acrylamide compound (D) Hydrophobized powder
10.WO/2022/106792ALTERNATIVE FOOD COMPRISING HERMETIA ILLUCENS MEAL FOR SHRIMP FARMING
WO 27.05.2022
Int.Class A23K 10/20
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
KFEEDING-STUFFS SPECIALLY ADAPTED FOR ANIMALS; METHODS SPECIALLY ADAPTED FOR PRODUCTION THEREOF
10Animal feeding-stuffs
20from material of animal origin
Appl.No PCT/FR2021/052050 Applicant INNOVAFEED Inventor RAY, Clément
The invention relates to the field of feeding decapods with insect meal. More particularly, the invention relates to an alternative food, comprising larvae meal of the Hermetia illucens species of black soldier fly, for shrimp farming. This food enables the weight gain, growth rate and food conversion rate of the shrimps to be maintained while decreasing the total amount of animal meal used.